Cite
Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin’s lymphoma.
MLA
Herishanu, Yair, et al. “Early-Mid Treatment C-Reactive Protein Level Is a Prognostic Factor in Aggressive Non-Hodgkin’s Lymphoma.” European Journal of Haematology, vol. 79, no. 2, Aug. 2007, pp. 150–54. EBSCOhost, https://doi.org/10.1111/j.1600-0609.2007.00894.x.
APA
Herishanu, Y., Perry, C., Braunstein, R., Metser, U., Goor, O., Rogowski, O., Berliner, S., Polliack, A., & Naparstek, E. (2007). Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin’s lymphoma. European Journal of Haematology, 79(2), 150–154. https://doi.org/10.1111/j.1600-0609.2007.00894.x
Chicago
Herishanu, Yair, Chava Perry, Rony Braunstein, Ur Metser, Odelia Goor, Ori Rogowski, Shlomo Berliner, Aaron Polliack, and Elizabeth Naparstek. 2007. “Early-Mid Treatment C-Reactive Protein Level Is a Prognostic Factor in Aggressive Non-Hodgkin’s Lymphoma.” European Journal of Haematology 79 (2): 150–54. doi:10.1111/j.1600-0609.2007.00894.x.